Latest IBD Stories

redOrbit Staff & Wire Reports - Your Universe Online Using DNA genotyping technology, researchers from the Wellcome Trust Sanger Institute have determined that primary sclerosing cholangitis (PSC), a rare autoimmune disease affecting the liver, is a unique condition and not a complication of inflammatory bowel disease (IBD). “Before our study, it was never quite clear whether PSC was a complication of IBD or a distinct disease in its own right. We have proven it to be a unique...

Research is the first to shed light on how harmful gut bacteria thrive in the intestine Scientists have long puzzled over why “bad” bacteria such as E. coli can thrive in the guts of those with inflammatory bowel disease (IBD), causing serious diarrhea. Now UC Davis researchers have discovered the answer—one that may be the first step toward finding new and better treatments for IBD. The researchers discovered a biological mechanism by which harmful bacteria grow, edge out...

OAKLAND, Calif., Dec. 13, 2012 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today its 2013 Innovator Awards Program for Inflammatory Bowel Disease (IBD). The Program supports "out-of-the-box" innovative research projects that are potentially transformative to the Foundation's efforts to diagnose, treat and/or cure IBD. The Program is open to tenure track professors (or the equivalent) at all levels from any scientific discipline and from any non-profit research...

OAKLAND, Calif., Nov. 30, 2012 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today its next Innovations Symposium, which will be held on Friday, July 12, 2013 at The Four Seasons Hotel Chicago. This unique one-day symposium will bring together preeminent investigators from a variety of disciplines to present their cutting-edge research on the molecular and cellular aspects of inflammatory and stress response pathways presented in the context of Inflammatory...

Provide new insights on Infliximab use, disease characteristics, fistulizing Crohn's disease Three separate studies presented today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas help to advance understanding of the differences between African American and Caucasian patients with Inflammatory Bowel Disease (IBD) and provide clinicians with new insight on how racial disparities involving disease characteristics, infliximab use, and...

SAN DIEGO, Oct. 22, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, will present five abstracts at the American College of Gastroenterology 2012 Scientific Meeting taking place this week in Las Vegas, NV. These data add to the compelling body of evidence that supports standardized use of liquid phase assays in helping to identify potential causes for loss of treatment response among inflammatory bowel disease (IBD) patients...

OAKLAND, Calif., Aug. 24, 2012 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation (KRF) announced today the recipients of its 2012 Innovator Awards and its 2012 Breakthrough Awards for Inflammatory Bowel Disease (IBD) research. Innovator Award recipients will each receive a $100,000 grant to support their respective innovative research projects. Breakthrough Awards are extended to existing KRF Innovator Award recipients, whose projects have demonstrated significant promise...

Lee Rannals for redOrbit.com – Your Universe Online A deadly disease outbreak that devastates boa constrictors and pythons has been discovered, which scientists call Inclusion Body Disease (IBD). This disease outbreak among snakes is being investigated by scientists at the Steinhart Aquarium in San Francisco. The team said they may have found a virus that is responsible for this common, but deadly disease, which could ultimately help lead to prevention and treatment options. IBD is...

HORSHAM, Pa. and LEIDEN, Netherlands, July 16, 2012 /PRNewswire/ -- Janssen Biotech, Inc. and Janssen Biologics B.V. announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMA) requesting approval of SIMPONI® (golimumab) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response...

HORSHAM, Pa., June 25, 2012 /PRNewswire/ -- In advance of releasing his debut album, musician and American Idol alumnus Casey Abrams has created an original song entitled "Chip on Your Shoulder" and music video inspired by his personal experience with inflammatory bowel disease (IBD) and the people he met through the national disease awareness campaign IBD Icons. Starting today, people can view Abrams' music video by joining the fan club at www.IBDIcons.com. For every fan who...